These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 6438393

  • 21. Aspartylglycosaminuria, urinary excretion of aspartylglycosamines related to mental retardation.
    Borud O, Torp KH, Dahl T.
    Monogr Hum Genet; 1978; 10():23-6. PubMed ID: 723900
    [No Abstract] [Full Text] [Related]

  • 22. [Findings on total hydroxyproline excretion in patients with scoliosis].
    Agostini S, Scalella P, Fabris D.
    Clin Ortop; 1974; 25(4):205-8. PubMed ID: 4471240
    [Abstract] [Full Text] [Related]

  • 23. [Diagnosis of aspartylglycosaminuria in a nine year-old girl admitted to pediatric psychiatry].
    Loiseau-Corvez MN, Bonnaure M, Le Berre C, Jezequel C.
    Pediatrie; 1992; 47(3):191-4. PubMed ID: 1319042
    [Abstract] [Full Text] [Related]

  • 24. Aspartylglycosaminuria diagnosed by routine urine amino acid assay.
    Rudy JL.
    Clin Chem; 1988 Oct; 34(10):2164. PubMed ID: 3168251
    [No Abstract] [Full Text] [Related]

  • 25. [Investigation on urinary hydroxyproline--influence of skin collagen on urinary hydroxyproline and its adjustment by hydroxyproline--creatinine ratio].
    Yamada Y.
    Nihon Seikeigeka Gakkai Zasshi; 1970 Aug; 44(8):601-12. PubMed ID: 5530072
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Study of the metabolism of connective tissue in viral hepatitis in children according to data on the excretion of hydroxyproline].
    Zhivitsa LV.
    Vopr Okhr Materin Det; 1974 Sep; 19(9):16-9. PubMed ID: 4418999
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Excessive infantile growth and early pubertal growth spurt: typical features in patients with aspartylglycosaminuria.
    Arvio P, Arvio M, Marttinen E, Sipilä I, Pirinen S.
    J Pediatr; 1999 Jun; 134(6):761-3. PubMed ID: 10356147
    [Abstract] [Full Text] [Related]

  • 31. The determination of urinary 3-trans-hydroxyproline (3 OHP). II. Normal values in neonates, infants and preschool children.
    Weiss MT, Weninger M, Häusler J, Lubec G.
    Padiatr Padol; 1988 Jun; 23(2):109-14. PubMed ID: 2841634
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Aspartylglucosamine excretion in heterozygous carriers of aspartylglycosaminuria.
    Mononen TK.
    Clin Chim Acta; 1989 Mar 15; 180(1):99-101. PubMed ID: 2743573
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Enzyme replacement therapy in a mouse model of aspartylglycosaminuria.
    Dunder U, Kaartinen V, Valtonen P, Väänänen E, Kosma VM, Heisterkamp N, Groffen J, Mononen I.
    FASEB J; 2000 Feb 15; 14(2):361-7. PubMed ID: 10657992
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical and biochemical delineation of aspartyl-glycosaminuria as observed in two members of an Italian family.
    Gehler J, Sewell AC, Becker C, Hartmann J, Spranger J.
    Helv Paediatr Acta; 1981 Feb 15; 36(2):179-89. PubMed ID: 6788730
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.